Market Analysis and Insights: Global Lung Tumor Embolization Market
Transcatheter bronchial arterial chemoembolization is a minimally invasive operation. To put it simply, in the case of no operation, a tiny channel with a diameter of about 2 mm is made on the skin. Under the guidance of angiography machine, the tumor blood supply vessels are found and then the chemotherapy drugs are infused through the catheter, and then the tumor blood vessel is embolized with embolization agent to block the tumor blood supply. For the tumor is to kill (high concentration of anticancer drugs) + "starve to death (blocking tumor blood vessels) double treatment of the tumor, the local lesions for the least trauma treatment method.
The global Lung Tumor Embolization market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Transarterial chemoembolization (TACE) accounting for % of the Lung Tumor Embolization global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Lung Tumor Embolization market size is valued at US$ million in 2021, while the North America and Europe Lung Tumor Embolization are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Lung Tumor Embolization landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Tumor Embolization market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Tumor Embolization market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Tumor Embolization market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Tumor Embolization market.
Global Lung Tumor Embolization Scope and Market Size
Lung Tumor Embolization market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Lung Tumor Embolization market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Transarterial chemoembolization (TACE)
Transarterial Radioembolization (TARE)
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Inari Medical
Penumbra
Tendfo
Medtronic
Olympus